Bacteria in cancer initiation, promotion and progression

Area of Science:

• Oncology
• Microbiology
• Immunology

Background:

• Cancer arises from genetic mutations, but environmental factors like the microbiome significantly influence neoplastic cell behavior and the tumor microenvironment.
• Gut microbiome dysbiosis is a recognized hallmark of cancer, yet specific microbial roles in tumorigenesis and immune modulation are still being elucidated.
• Research over two decades has highlighted the microbiome's impact on health and disease, prompting investigation into microbiota-focused health strategies.

Purpose of the Study:

• To review the evolving understanding of how the microbiota influences cancer initiation, promotion, and progression.
• To explore the specific roles of bacteria in various cancers, including gastrointestinal, lung, breast, and prostate malignancies.
• To discuss the potential and challenges of utilizing bacteria-based strategies for personalized cancer prevention, diagnostics, and treatment.

Main Methods:

• Literature review of scientific studies on the human microbiome and cancer.
• Analysis of mechanisms by which microbiota impacts cancer development.
• Exploration of bacterial roles in specific cancer types and therapeutic strategies.

Main Results:

• The microbiota significantly impacts cancer initiation, promotion, and progression through various mechanisms.
• Specific bacteria have been implicated in gastrointestinal, lung, breast, and prostate cancers.
• Targeting or harnessing the microbiome presents promising, yet challenging, avenues for personalized cancer care.

Conclusions:

• The microbiota plays a critical role in cancer development and progression.
• Further research into microbial mechanisms is essential for developing effective cancer interventions.
• Harnessing the microbiome holds potential for personalized cancer prevention, diagnostics, and treatment, but requires careful consideration of limitations.